Session VI: Multiple Myeloma
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
How Does Genetics and MRD Impact Myeloma Treatment Or Doesn’t It?
FEATURING
Ajay Nooka
- 250 views
- October 24, 2018
- 1
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Novel Agents, Antibodies, Targeted Therapies and Related Studies in Myeloma
FEATURING
Thomas Martin
- 262 views
- October 24, 2018
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Management and Diagnosis of Amyloid: What Is New?
FEATURING
Suzanne Lentzsch
- 278 views
- October 24, 2018
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Emerging Data on Management and Imaging of Myeloma Bone Disease
FEATURING
Meletios Dimopoulos
- 346 views
- October 24, 2018
- 2
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
What Will The Future Hold for Myeloma Treatment CARTs vs BiTES?
FEATURING
Robert Z. Orlowski
- 427 views
- October 24, 2018
- 2
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
The Role of ASCT In The Era of Modern MM Therapy
FEATURING
Peter Voorhees
- 468 views
- October 24, 2018
- 1
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FDA Approves Selinexor for Refractory Multiple Myeloma, STORM Study
FEATURING
Sundar Jagannath
- 162 views
- October 24, 2018
- 1
